Loading company…
Shanghai-based developer of minimally invasive vascular intervention devices for stroke and peripheral vascular disease.
Established in 2014 and based in Shanghai, China, Skynor Medical develops minimally invasive vascular intervention products and has 3000 square meters of research, production and office space. Its neurovascular products include the SkyFlow intracranial embolization stent, the SkySurfer distal access catheter and the SkyWay microtubule. In 2020 the company raised approximately RMB 100 million in Series B funding led by Zeyue Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in